Search results for “Neurofilament light” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 61 patents, we discovered top 18 key players by total patent application. Coherus BioSciences, Inc., Santen Pharmaceutical Co., Ltd., MedImmune Ltd. are dominant in this area. They take 44.26% of the total patent filing.
Coherus BioSciences, Inc.
California, United States
Patent: 12
Santen Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 9
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 6
Brain Biomarker Solutions in Gothenburg AB
Sweden
Patent: 6
Eli Lilly & Co.
Indiana, United States
Patent: 5
Denali Therapeutics, Inc.
California, United States
Patent: 5
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 2
Quanterix Corp.
Massachusetts, United States
Patent: 2
Board of Regents of The University of Oklahoma
Oklahoma, United States
Patent: 2
STARTUP
Prilenia Therapeutics Development Ltd.
Israel
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 3 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Prilenia Therapeutics Development Ltd.
Israel
Patent: 2
STARTUP
TrueBinding, Inc.
California, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 55 patents applied in the last 5 years. We discover 27 most active companies in this area. The fast-growing Coherus BioSciences, Inc., MedImmune Ltd., Denali Therapeutics, Inc. take 41.82% of patent filing during this period.
Coherus BioSciences, Inc.
California, United States
Patent: 12
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 6
Denali Therapeutics, Inc.
California, United States
Patent: 5
Eli Lilly & Co.
Indiana, United States
Patent: 5
University of Miami
United States
Patent: 3
Queen Mary University of London
United Kingdom
Patent: 3
University of Florida
United States
Patent: 2
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 2
Genuv, Inc.
South Korea
Patent: 2
Washington University in St. Louis
Missouri, United States
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 55 patents in last 5 years, we discover 26 new entrants. Coherus BioSciences, Inc., MedImmune Ltd., Denali Therapeutics, Inc. are the most active new entrants in this area.
Coherus BioSciences, Inc.
California, United States
Patent: 12
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 6
Denali Therapeutics, Inc.
California, United States
Patent: 5
Eli Lilly & Co.
Indiana, United States
Patent: 5
University of Miami
United States
Patent: 3
Queen Mary University of London
United Kingdom
Patent: 3
University of Florida
United States
Patent: 2
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 2
Genuv, Inc.
South Korea
Patent: 2
Washington University in St. Louis
Missouri, United States
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 13 patents, we discovered top 5 universities and scientific research institutions by total patent application. University of Miami, Queen Mary University of London, Washington University in St. Louis are dominant in this area. They take 61.54% of the total patent filing.
University of Miami
United States
Patent: 3
Queen Mary University of London
United Kingdom
Patent: 3
Washington University in St. Louis
Missouri, United States
Patent: 2
Keio University
Tokyo-to, Japan
Patent: 1
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: